Site mutation analysis revealed that ubiquitination at STAT6 K450 plays a crucial role in TRAF3-mediated STAT6 activation, which promotes increased expression of M2-associated surface markers as well as tumor progression. The gene discussed is STAT6; the disease is neoplasm.